Retatrutide Evaluated for Obesity and Knee Osteoarthritis in Completed Study | Retatrutide News

A study on retatrutide for obesity and knee osteoarthritis has been completed. It focused on safety and efficacy over 77 weeks.
Clinical Trials · October 17, 2026